| P2093 | author name string | Guochao Shi | |
| | Chunrong Huang | |
| P2860 | cites work | Analysis of the lung microbiome in the "healthy" smoker and in COPD | Q21091065 |
| | Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans | Q21133618 |
| | Disordered microbial communities in asthmatic airways | Q21562589 |
| | New Insights into Inflammatory Bowel Disease Pathophysiology: Paving the Way for Novel Therapeutic Targets | Q22241332 |
| | Innate Immunity in Crohnʼs Disease | Q22242728 |
| | Recent Insights Into the Genetics of Inflammatory Bowel Disease | Q22250935 |
| | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors | Q22252931 |
| | Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins | Q24621817 |
| | Structure, function and diversity of the healthy human microbiome | Q24626370 |
| | Metagenomic analysis of the human distal gut microbiome | Q24633486 |
| | Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis | Q24669753 |
| | Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients | Q24814235 |
| | Acute exacerbation of COPD | Q26749302 |
| | COPD and the microbiome | Q26768514 |
| | Inflammatory bowel disease as a model for translating the microbiome | Q26853123 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Cystic fibrosis | Q28250200 |
| | Crohn's disease | Q28273481 |
| | Cigarette smoking and infection | Q28292345 |
| | The effects of airway microbiome on corticosteroid responsiveness in asthma | Q28392911 |
| | Pathogens and host immunity in the ancient human oral cavity | Q28660564 |
| | Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment | Q28710518 |
| | A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease | Q28727685 |
| | Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 |
| | Tobacco smoke and involuntary smoking | Q29619429 |
| | Lung infections associated with cystic fibrosis | Q30080000 |
| | Bacterial species diversity in cigarettes linked to an investigation of severe pneumonitis in U.S. Military personnel deployed in operation iraqi freedom | Q30991677 |
| | Subacute Bacterial Endocarditis with Leptotrichia goodfellowii in a Patient with a Valvular Allograft: A Case Report and Review of the Literature. | Q31145208 |
| | Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals | Q33509530 |
| | Human pathogens abundant in the bacterial metagenome of cigarettes | Q33523227 |
| | Invasion strategies of the oral pathogen porphyromonas gingivalis: implications for cardiovascular disease | Q33655174 |
| | Heme oxygenase-1 and carbon monoxide regulate intestinal homeostasis and mucosal immune responses to the enteric microbiota | Q33779241 |
| | Disordered microbial communities in the upper respiratory tract of cigarette smokers | Q33781228 |
| | Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma | Q33782854 |
| | Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma | Q33793577 |
| | Smoking, use of moist snuff and risk of celiac disease: a prospective study | Q33864904 |
| | Smoking and increased Alzheimer's disease risk: a review of potential mechanisms | Q33902721 |
| | Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. | Q33907451 |
| | Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. | Q33995488 |
| | The Human Microbiome Project in 2011 and beyond | Q34054038 |
| | The ecology of genetically diverse infections | Q34250505 |
| | Composition of tobaccos from countries with high and low incidences of lung cancer. I. Selenium, polonium-210, Alternaria, tar, and nicotine. | Q34273537 |
| | Higher rates of Clostridium difficile infection among smokers | Q34359509 |
| | Inflammatory bowel disease and tobacco smoke--a case-control study | Q34393276 |
| | Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect | Q34410437 |
| | Periodontal microbial ecology | Q34413957 |
| | The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations | Q34437958 |
| | The lung microbiome in moderate and severe chronic obstructive pulmonary disease | Q34448176 |
| | Bicuspid aortic valve endocarditis caused by Gemella sanguinis: Case report and literature review | Q91166867 |
| | Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential | Q91975122 |
| | Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cells | Q93070834 |
| | Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer | Q93347337 |
| | Environmental risk factors for inflammatory bowel disease | Q93587626 |
| | Chemokine and cytokine levels in inflammatory bowel disease patients | Q36338594 |
| | Functional Metagenomics of the Bronchial Microbiome in COPD. | Q36345407 |
| | A tale of two risks: smoking, diabetes and the subgingival microbiome. | Q36378549 |
| | Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. | Q36431204 |
| | Recovery of Mycobacterium avium from cigarettes | Q36525509 |
| | Smoking rates and the state of smoking interventions for children and adolescents with chronic illness | Q36554209 |
| | The cystic fibrosis airway microbiome | Q36629083 |
| | Smoking as a trigger for inflammatory rheumatic diseases | Q36672505 |
| | Multicenter case-control study of the risk factors for ulcerative colitis in China | Q36715099 |
| | Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. | Q36850868 |
| | Microbiology of odontogenic bacteremia: beyond endocarditis | Q37050956 |
| | Comparison of the respiratory microbiome in healthy nonsmokers and smokers | Q37073006 |
| | Gut Microbial Diversity Is Reduced in Smokers with Crohn's Disease | Q37189929 |
| | The long-term stability of the human gut microbiota | Q37217949 |
| | Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. | Q37317826 |
| | Cigarette smoking and innate immunity | Q37358532 |
| | Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus | Q37487983 |
| | The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. | Q37501328 |
| | Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis | Q37502050 |
| | Oral microbiome and history of smoking and colorectal cancer | Q37590332 |
| | A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients | Q37594836 |
| | Effects of tobacco smoke on immunity, inflammation and autoimmunity | Q37665006 |
| | The intestinal microbiota in inflammatory bowel diseases: time to connect with the host | Q37743105 |
| | Diabetes mellitus and periodontitis: a tale of two common interrelated diseases | Q37895120 |
| | Impact of cigarette smoke exposure on host-bacterial pathogen interactions. | Q37898894 |
| | The oral microbiome in health and disease | Q38064217 |
| | Chronic ulcerative colitis and colorectal cancer | Q38128638 |
| | Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). | Q38214520 |
| | Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. | Q38263963 |
| | Current perspective of the impact of smoking on the progression and treatment of periodontitis | Q38286146 |
| | Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. | Q38657093 |
| | Effects of smoking on oral ecology. A review of the literature | Q38738959 |
| | Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease | Q39227281 |
| | Biofilms and host response - helpful or harmful | Q39240791 |
| | Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress. | Q39297856 |
| | Serial pH changes in the duodenal bulb during smoking | Q39310469 |
| | Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers | Q39413531 |
| | Cigarette smoking and the oral microbiome in a large study of American adults | Q39889154 |
| | Opportunistic Infection: A Review | Q40013750 |
| | Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. | Q40231814 |
| | Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator | Q40349670 |
| | Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study | Q40501515 |
| | Bacterial infection as a cause of cancer | Q41064472 |
| | Studies on the erythropoietic effect of plasma from anemic toads both with and without testis | Q41733373 |
| | Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice | Q42263596 |
| | Identification of bacterial and fungal components in tobacco and tobacco smoke | Q43008480 |
| | Allergenic fungi and actinomycetes in smoking materials and their health implications | Q43021037 |
| | NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. | Q43118703 |
| | Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction | Q43504466 |
| | Neutrophil superoxide production in the presence of cigarette smoke extract, nicotine and cotinine | Q43516494 |
| | Mucosal flora in Crohn's disease and ulcerative colitis - an overview. | Q43784311 |
| | Case report: severe acute Parkinsonism associated with streptococcal infection and antibasal ganglia antibodies | Q43941017 |
| | Nonenterococcal group-D streptococcal endocarditis caused by Streptococcus bovis | Q44216697 |
| | Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status | Q44264832 |
| | The differential effect of cigarette smoke on the growth of bacteria found in humans | Q44277886 |
| | Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis | Q34536205 |
| | Frequent detection of Streptococcus tigurinus in the human oral microbial flora by a specific 16S rRNA gene real-time TaqMan PCR. | Q34537955 |
| | Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. | Q34577688 |
| | Intestinal microbiota in inflammatory bowel disease: friend of foe? | Q34579729 |
| | The subgingival microbiome of clinically healthy current and never smokers. | Q34760422 |
| | Microbiota disbiosis is associated with colorectal cancer | Q35037563 |
| | Bacterial infections as a cause of cancer | Q35096949 |
| | Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease | Q35114878 |
| | Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi | Q35120262 |
| | Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 |
| | Subgingival microbiota in health compared to periodontitis and the influence of smoking | Q35169436 |
| | Emerging cystic fibrosis pathogens and the microbiome | Q35169553 |
| | Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. | Q35250967 |
| | Subgingival microbiome in smokers and non-smokers in Korean chronic periodontitis patients | Q35302484 |
| | Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies | Q35328218 |
| | Advancing respiratory research | Q35410986 |
| | Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 |
| | Gut microbiome development along the colorectal adenoma-carcinoma sequence | Q35574864 |
| | Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa. | Q35646925 |
| | Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites | Q35671726 |
| | The Influence of Smoking on the Peri-Implant Microbiome | Q35678207 |
| | Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements | Q35681203 |
| | The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment | Q35716503 |
| | The airway microbiome in patients with severe asthma: Associations with disease features and severity. | Q35721479 |
| | Cigarette smoking and the periodontal patient | Q35739602 |
| | Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters | Q35773313 |
| | Immunopathogenesis of IBD: current state of the art. | Q35857951 |
| | Subgingival Microbial Profiles of Smokers with Periodontitis | Q35866602 |
| | Asthma and cigarette smoking. | Q35933941 |
| | The lung microbiome and exacerbations of COPD. | Q35952878 |
| | XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented? | Q35956144 |
| | Genotoxicity of tobacco smoke and tobacco smoke condensate: a review | Q35968076 |
| | Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes | Q35989768 |
| | Emerging pathogenic links between microbiota and the gut-lung axis. | Q36150861 |
| | Cigarette smoking and the microbial flora of the mouth | Q44889612 |
| | Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers | Q46249728 |
| | Airway microbiota across age and disease spectrum in cystic fibrosis | Q46259966 |
| | Smoking May Lead to Marginal Bone Loss Around Non-Submerged Implants During Bone Healing by Altering Salivary Microbiome: A Prospective Study. | Q46315884 |
| | Cigarette smoke effects on innate immune mechanisms in the nasal mucosa. Potential effects on the microbiome | Q46584455 |
| | Cigarette smoking inhibits acid-stimulated duodenal mucosal bicarbonate secretion | Q46602834 |
| | Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer | Q46663786 |
| | Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. | Q46720733 |
| | The gut microbiome in health and disease | Q46913518 |
| | Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer | Q47657457 |
| | Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis | Q47750206 |
| | Recovery of potential pathogens and interfering bacteria in the nasopharynx of smokers and nonsmokers | Q47782465 |
| | Maturation of the gut microbiome and risk of asthma in childhood | Q48267558 |
| | Current smoking improves ulcerative colitis patients' disease behaviour in the northwest of China | Q49372195 |
| | Mutagenicity of pyrolysates of salt-tolerant bacteria from food and cigarettes | Q50211789 |
| | Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study. | Q50928110 |
| | Subgingival microbiome in smokers and non-smokers in periodontitis: an exploratory study using traditional targeted techniques and a next-generation sequencing. | Q51535370 |
| | Alterations in Enteric Virome Associate With Colorectal Cancer and Survival Outcomes. | Q54229182 |
| | Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. | Q54348400 |
| | Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis. | Q54380862 |
| | Rheumatoid arthritis: Prevotella copri associated with new-onset untreated RA. | Q54536068 |
| | Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome | Q57022552 |
| | Types of tobacco consumption and the oral microbiome in the United Arab Emirates Healthy Future (UAEHFS) Pilot Study | Q57174461 |
| | Association between Cigarette Smoking Status and Composition of Gut Microbiota: Population-Based Cross-Sectional Study | Q58198306 |
| | Influence of cigarette smoking on the human duodenal mucosa-associated microbiota | Q58694782 |
| | A metagenomic study of the gut microbiome in Behcet's disease | Q58800559 |
| | Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention | Q59411245 |
| | Effects of smoking on the lower respiratory tract microbiome in mice | Q60044802 |
| | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 |
| | subspecies engineered to produce mycosporin-like amino acids in colorectal cancer prevention | Q61812084 |
| | Streptococcus sanguinis biofilm formation & interaction with oral pathogens. | Q64973509 |
| | Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion | Q67744478 |
| | Two cases of "heavy chain disease" | Q71059205 |
| | Gastric cancer | Q73738910 |
| | The prevalence of pathogenic periodontal microflora in healthy young adult smokers | Q73781214 |
| | Bacterial endotoxin is an active component of cigarette smoke | Q74619159 |
| | Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis | Q76390548 |
| | Subgingival plaque microbiota in HIV positive patients | Q79797755 |
| | Recovery of potential pathogens in the nasopharynx of healthy and otitis media-prone children and their smoking and nonsmoking parents | Q79820554 |
| | Fecal microbiota in early rheumatoid arthritis | Q81403677 |
| | Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease | Q81458923 |
| | Tobacco flakes on cigarette filters grow bacteria: a potential health risk to the smoker? | Q81924438 |
| | The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases | Q84002918 |
| | Cigarette smoke decreases organic acids levels and population of bifidobacterium in the caecum of rats | Q84236971 |
| | Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin | Q84488767 |
| | Periodontal disease in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003) | Q84564250 |
| | Effects of cigarette smoke condensate on the production and characterization of exopolysaccharides by Bifidobacterium | Q85349548 |
| | Insights into the human oral microbiome | Q88153217 |
| | Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection | Q89567847 |
| P433 | issue | 1 | |
| P304 | page(s) | 225 | |
| P577 | publication date | 2019-07-15 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Smoking and microbiome in oral, airway, gut and some systemic diseases | |
| P478 | volume | 17 | |